Hisatsugu Koshimizu

Hisatsugu Koshimizu

Auto-generated profile, based on publicly available information

Hisatsugu Koshimizu

Institute for Comprehensive Medical Science Fujita Health University Toyoake Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2004 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SSShingo Suzuki
Shingo Suzuki
TNTadahiro Numakawa
Tadahiro Numakawa
KSKazuhiro Shimazu
Kazuhiro Shimazu
HKHisatsugu Koshimizu
Hisatsugu Koshimizu
THTomoko Hara
Tomoko Hara
MKMasami Kojima
Masami Kojima
Brain-derived neurotrophic factor (BDNF) plays an important role in synaptic plasticity but the underlying signaling mechanisms remain unknown. Here, we show that BDNF rapidly recruits full-length TrkB (TrkB-FL) receptor into cholesterol-rich lipid rafts from nonraft regions of neuronal plasma membranes. Translocation of TrkB-FL was blocked by Trk inhibitors, suggesting a role of TrkB tyrosine kinase in the translocation. Disruption of lipid rafts by depleting cholesterol from cell surface blocked the ligand-induced translocation. Moreover, disruption of lipid rafts prevented potentiating effects of BDNF on transmitter release in cultured neurons and synaptic response to tetanus in hippocampal slices. In contrast, lipid rafts are not required for BDNF regulation of neuronal survival. Thus, ligand-induced TrkB translocation into lipid rafts may represent a signaling mechanism selective for synaptic modulation by BDNF in the central nervous system.

13 August 2009 in Molecular Brain
Verified
Journal Article
Open access
PDF file
HKHisatsugu Koshimizu
Hisatsugu Koshimizu
KKKazuyuki Kiyosue
Kazuyuki Kiyosue
THTomoko Hara
Tomoko Hara
SHShunsuke Hazama
Shunsuke Hazama
SSShingo Suzuki
Shingo Suzuki
MKMasami Kojima
Masami Kojima
Background: Proneurotrophins and mature neurotrophins elicit opposite effects via the p75 neurotrophin receptor (p75NTR) and Trk tyrosine kinase receptors, respectively; however the molecular roles of proneurotrophins in the CNS are not fully understood.Results: Based on two rare single nucleotide polymorphisms (SNPs) of thehuman brain-derived neurotrophic factor (BDNF)gene, we generated R125M-, R127L- and R125M/R127L-BDNF, which have amino acid substitution(s) near the cleavage site between the pro- and mature-domain of BDNF. Western blot analyses demonstrated that these BDNF variants are poorly cleaved and result in the predominant secretion of proBDNF. Using these cleavage-resistant proBDNF (CR-proBDNF) variants, the molecular and cellular roles of proBDNF on the CNS neurons were examined. First, CR-proBDNF showed normal intracellular distribution and secretion in cultured hippocampal neurons, suggesting that inhibition of proBDNF cleavage does not affect intracellular transportation and secretion of BDNF. Second, we purified recombinant CR-proBDNF and tested its biological effects using cultured CNS neurons. Treatment with CR-proBDNF elicited apoptosis of cultured cerebellar granule neurons (CGNs), while treatment with mature BDNF (matBDNF) promoted cell survival. Third, we examined the effects of CR-proBDNF on neuronal morphology using more than 2-week cultures of basal forebrain cholinergic neurons (BFCNs) and hippocampal neurons. Interestingly, in marked contrast to the action of matBDNF, which increased the number of cholinergic fibers and hippocampal dendritic spines, CR-proBDNF dramatically reduced the number of cholinergic fibers and hippocampal dendritic spines, without affecting the survival of these neurons.Conclusion: These results suggest that proBDNF has distinct functions in different populations of CNS neurons and might be responsible for specific physiological cellular processes in the brain.

6 February 2013 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
KTKeizo Takao
Keizo Takao
KKKatsunori Kobayashi
Katsunori Kobayashi
HHHideo Hagihara
Hideo Hagihara
KOKoji OHIRA
Koji OHIRA
HSHirotaka Shoji
Hirotaka Shoji
TMTsuyoshi Miyakawa
Tsuyoshi Miyakawa
Schnurri-2 (Shn-2), an nuclear factor-κB site-binding protein, tightly binds to the enhancers of major histocompatibility complex class I genes and inflammatory cytokines, which have been shown to harbor common variant single-nucleotide polymorphisms associated with schizophrenia. Although genes related to immunity are implicated in schizophrenia, there has been no study showing that their mutation or knockout (KO) results in schizophrenia. Here, we show that Shn-2 KO mice have behavioral abnormalities that resemble those of schizophrenics. The mutant brain demonstrated multiple schizophrenia-related phenotypes, including transcriptome/proteome changes similar to those of postmortem schizophrenia patients, decreased parvalbumin and GAD67 levels, increased theta power on electroencephalograms, and a thinner cortex. Dentate gyrus granule cells failed to mature in mutants, a previously proposed endophenotype of schizophrenia. Shn-2 KO mice also exhibited mild chronic inflammation of the brain, as evidenced by increased inflammation markers (including GFAP and NADH/NADPH oxidase p22 phox), and genome-wide gene expression patterns similar to various inflammatory conditions. Chronic administration of anti-inflammatory drugs reduced hippocampal GFAP expression, and reversed deficits in working memory and nest-building behaviors in Shn-2 KO mice. These results suggest that genetically induced changes in immune system can be a predisposing factor in schizophrenia.

13 June 2007 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SSShingo Suzuki
Shingo Suzuki
KKKazuyuki Kiyosue
Kazuyuki Kiyosue
SHShunsuke Hazama
Shunsuke Hazama
AOAkihiko Ogura
Akihiko Ogura
MKMegumi Kashihara
Megumi Kashihara
MKMasami Kojima
Masami Kojima
Brain-derived neurotrophic factor (BDNF) exerts multiple biological functions in the CNS. Although BDNF can control transcription and protein synthesis, it still remains open to question whether BDNF regulates lipid biosynthesis. Here we show that BDNF elicits cholesterol biosynthesis in cultured cortical and hippocampal neurons. Importantly, BDNF elicited cholesterol synthesis in neurons, but not in glial cells. Quantitative reverse transcriptase-PCR revealed that BDNF stimulated the transcription of enzymes in the cholesterol biosynthetic pathway. BDNF-induced cholesterol increases were blocked by specific inhibitors of cholesterol synthesis, mevastatin and zaragozic acid, suggesting that BDNF stimulates de novo synthesis of cholesterol rather than the incorporation of extracellular cholesterol. Because cholesterol is a major component of lipid rafts, we investigated whether BDNF would increase the cholesterol content in lipid rafts or nonraft membrane domains. Interestingly, the BDNF-mediated increase in cholesterol occurred in rafts, but not in nonrafts, suggesting that BDNF promotes the development of neuronal lipid rafts. Consistent with this notion, BDNF raised the level of the lipid raft marker protein caveolin-2 in rafts. Remarkably, BDNF increased the levels of presynaptic proteins in lipid rafts, but not in nonrafts. An electrophysiological study revealed that BDNF-dependent cholesterol biosynthesis plays an important role for the development of a readily releasable pool of synaptic vesicles. Together, these results suggest a novel role for BDNF in cholesterol metabolism and synapse development.

1 April 2010 in Neuroscience Letters
Verified
Journal Article
Closed access
HKHisatsugu Koshimizu
Hisatsugu Koshimizu
SHShunsuke Hazama
Shunsuke Hazama
THTomoko Hara
Tomoko Hara
AOAkihiko Ogura
Akihiko Ogura
MKMasami Kojima
Masami Kojima

20 June 2008 in Hippocampus
Verified
Journal Article
Closed access
PDF file
AWAlicja Woronowicz
Alicja Woronowicz
HKHisatsugu Koshimizu
Hisatsugu Koshimizu
SCSu‐Youne Chang
Su‐Youne Chang
NCNiamh X. Cawley
Niamh X. Cawley
JHJoanna M. Hill
Joanna M. Hill
YLY Peng Loh
Y Peng Loh